Products & Services · Total Revenue
Net product sales — Total Revenue
Moderna Net product sales — Total Revenue decreased by 45.5% to $352.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 309.3%, from $86.00M to $352.00M. Over 4 years (FY 2021 to FY 2025), Net product sales — Total Revenue shows a downward trend with a -43.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates successful commercialization and market adoption of the segment's product offerings.
Detailed definition
This represents the total net revenue recognized from the sale of commercial products within a specific business segment...
Peer comparison
Standard revenue reporting across all commercial-stage biotech and pharmaceutical companies.
Metric ID:
mrna_segment_net_product_sales_total_revenueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.20B | $4.81B | $6.94B | $5.93B | $4.53B | $3.12B | $4.86B | $1.83B | $293.00M | $1.76B | $2.79B | $167.00M | $184.00M | $1.82B | $938.00M | $86.00M | $114.00M | $973.00M | $646.00M | $352.00M |
| QoQ Change | — | +14.6% | +44.2% | -14.6% | -23.5% | -31.1% | +55.7% | -62.4% | -84.0% | +499.7% | +59.0% | -94.0% | +10.2% | +889.1% | -48.5% | -90.8% | +32.6% | +753.5% | -33.6% | -45.5% |
| YoY Change | — | — | — | — | +8.0% | -35.1% | -29.9% | -69.1% | -93.5% | -43.7% | -42.5% | -90.9% | -37.2% | +3.6% | -66.4% | -48.5% | -38.0% | -46.5% | -31.1% | +309.3% |
Range$86.00M – $6.94B
CAGR-40.7%
Avg YoY Growth-22.0%
Median YoY Growth-40.3%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's net product sales — total revenue?
- Moderna (MRNA) reported net product sales — total revenue of $352.00M in Q1 2026.
- How has Moderna's net product sales — total revenue changed year-over-year?
- Moderna's net product sales — total revenue increased by 309.3% year-over-year, from $86.00M to $352.00M.
- What is the long-term trend for Moderna's net product sales — total revenue?
- Over 4 years (2021 to 2025), Moderna's net product sales — total revenue has grown at a -43.4% compound annual growth rate (CAGR), from $17.68B to $1.82B.
- What does net product sales — total revenue mean?
- The total net income generated from selling products in this business segment.